40
2022Brood
AGENCY STATEMENT
We use creativity to make the world a healthier, happier place. We build Brands that Matter - creating campaigns that turn your health and wellness product into a brand to truly believe in. This is Advertising for Good- we don't work for brands that don't do anything to benefit the greater good.

- Agency description
At brood our goal is to work only with products that make a meaningful difference to the lives of the people who use or take them. We don’t promote fast foods to the kids who already have a 25% chance of being obese before they reach adulthood1 ; increasing their risk of type 2 diabetes, cancer, heart and liver disease.
Instead we choose to work in areas where we believe we can make a positive contribution to society. We create advertising campaigns that turn highly technical and complex products into brands that people can truly believe in.
It’s wrong to assume that every product that helps alleviate people’s suffering or improves their health will become a trusted brand; or that a product that is objectively the ‘best’ in its category will become a market leader. Price (especially when the NHS is the buyer), promotional spend, convention and inertia all conspire to prevent many great products from reaching their potential.
So how do we help our clients guarantee that their product is successful? Simple. We strive to find the key insight into the behavior of our audience that will allow us to create effective brand differentiation. This insight forms the basis of highly creative work that communicates meaningful benefits and compelling reasons to believe.
With this platform we turn products into brands that are trusted by doctors and chosen by consumers. Brands that change lives. Brands that make a difference.
In short, we create Brands That Matter
The work we do can make the world a healthier, happier place. To us, that matters. Does it matter to you?
1. National Child Measurement Programme 2020/21. At age 10-11 (year 6), 25.5% of children in the UK are obese and 15.4% overweight.
- Contact details
- 13a Goswell Hill Windsor SL4 1RH
- 01753 314400
- kelly@wearebrood.co.uk
- https://www.wearebrood.co.uk
- Key contact
- Kelly Underwood-Fone
- Co-Founder and Director
- kelly@wearebrood.co.uk
- 07870603136
- 2022 Agency Data
-
2021 awardsTotal staff10-24 staffBillings from UK creative healthcare workHealthcare staff10-24 staffTotal agency billingsAgency ageBetween 3 and 5 yearsSocial media footprintStatusINDEPENDENTApproximate percentage of advertising, branding, creative or design work in the UK healthcare market90-100%
- This information was supplied or confirmed by Brood. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
COVID-19 Updates and Daily News
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
Quick links
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Genmab hires first chief operating officer
- A relentless commitment to neuroscience
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...